Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Vega

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Cureus|August 9, 2021
Characteristics of Serrated Adenomas in Non-Hispanic Whites and African Americans Undergoing Screening ColonoscopyLauren Stemboroski, Joshua Samuel, Ahmad Alkaddour, et al.
Digestive Diseases and Sciences|October 7, 2014
DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinomaJoshua Whorton, Sripathi M Sureban, Randal May, et al.
Acta Biochimica Et Biophysica Sinica|May 13, 2020
Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrenceJiannan Yao, Xinying Xue, Dongfeng Qu, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Nonspecific motility disorders, irritable esophagus, and chest painAnne Lund Krarup, Donghua Liao, Hans Gregersen, et al.
Annals of the New York Academy of Sciences|February 6, 2026
Antireflux Surgery for Barrett's Esophagus: Where Do We Stand in Preventing Esophageal Adenocarcinoma?Dagmar Kollmann, Cansel Etyemez, Reza Asari, et al.
Cancer Research|June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 KinaseNathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
Journal of Gastroenterology and Hepatology|September 16, 2011
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinomaKenneth J Vega, Randal May, Sripathi M Sureban, et al.
International Journal of Cancer|March 27, 2018
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancerYang Ge, Nathaniel Weygant, Dongfeng Qu, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Translational research on Barrett's esophagusAnushka Baruah, Navtej Buttar, Raghav Chandra, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cureus|August 9, 2021
Characteristics of Serrated Adenomas in Non-Hispanic Whites and African Americans Undergoing Screening ColonoscopyLauren Stemboroski, Joshua Samuel, Ahmad Alkaddour, et al.
Digestive Diseases and Sciences|October 7, 2014
DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinomaJoshua Whorton, Sripathi M Sureban, Randal May, et al.
Acta Biochimica Et Biophysica Sinica|May 13, 2020
Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrenceJiannan Yao, Xinying Xue, Dongfeng Qu, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Nonspecific motility disorders, irritable esophagus, and chest painAnne Lund Krarup, Donghua Liao, Hans Gregersen, et al.
Annals of the New York Academy of Sciences|February 6, 2026
Antireflux Surgery for Barrett's Esophagus: Where Do We Stand in Preventing Esophageal Adenocarcinoma?Dagmar Kollmann, Cansel Etyemez, Reza Asari, et al.
Cancer Research|June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 KinaseNathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
Journal of Gastroenterology and Hepatology|September 16, 2011
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinomaKenneth J Vega, Randal May, Sripathi M Sureban, et al.
International Journal of Cancer|March 27, 2018
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancerYang Ge, Nathaniel Weygant, Dongfeng Qu, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Translational research on Barrett's esophagusAnushka Baruah, Navtej Buttar, Raghav Chandra, et al.
Pageof 8